1[1]Hillis SD,Owens LM,Marchbanks PA, et al. Recurrent chlamydial infection increase the risks of hospitalia\zation of ectopic pregnancy and pelvic inflammatory disease[J].Am J Obstet Gynecol, 1997,176:103-107.
4Jose-Miller AB, Boyden JW, Frey KA. Infertility [J]. Am Fam Phy- sician, 2007, 75(6): 849-856.
5Stephens A J, Aubuchon M, Schust DJ. Antichlamydial antibodies, human fertility, and pregnancy wastage [J].Infect Dis Obstet Gyne- col, 2011, doi: 10.1155/2011/525182.
6Wagcnlchner FM, W~idncr W, Naber KG. Chlamydial infections in urology [J]. World J Urol, 2006, 24(1): 4-12.
7Idahl A, Lundin E, JursWand M, ct al. Chlamydia trachomatis and Mycoplasma gcnitalium plasma antibodies in relation to epithelial ovarian tumors [J]. Infect Dis Obstvt Gynecol, 2011, doi:10.1155/ 2011/824627.
8Barlow RE, Cooke ID, Odukoya O. et al. The prevalence of Chla- mydia trachomatis in fresh tissue specimens from patients with ecto- pic pregnancy or tubal factor infertility as determined by PCR and in-siva hybridisation [J]. J Med Microbiol, 2001.50(10): 902-908.
9den Hartog JE, Land JA, Stassen FR, et al. The role of chlamydia ge- nus-specific and species-specific Ig(} antibody testing in predicting tubal disease in subfertile women [J]. Hum Reprod, 2004, 19(6): 1380-1384.
10den Hartog JE, Lardenoije CM, Severens JL, et al. Screening strate- gies for tubal factor subfertility [J]. Hum Reprod, 2008. 23(8): 1840-1848.
